This marcus evans conference will give you a detailed guide to increasing organizational value and the tools to sharpen productivity to its maximum potential. It is easy to feel disorganized in an industry that is constantly evolving and innovating, so taking a step back to focus on aligning the portfolio to an overarching strategy and re-evaluating best practices for prioritization, modeling, resource allocation, and strategy will re-charge growth. This conference will also examine how to make the most of our internal team, while concurrently strengthening our external relationships.

Read on marcusevans.com

With advances in changing modalities due to reduced capacity, the industry is challenged to shift their thinking not just to increase capacity but to reduce cycle times, make modality choices and modify sterility validations while keeping up with regulatory changes and maintaining device quality. This event brings together voices from sterilization stakeholders to define and build the future of this industry, for the benefit of the patients.

Read on marcusevans.com

This conference will provide attendees with lessons learned and recent approaches on Chemical Characterization, Classifications for Hazardous Chemical Substances, In Vitro vs In Vivo Testing, Toxicological Risk Assessments, and Product Lifecycle Management.  Additionally, attendees will walk away with actionable takeaways about how to navigate evolving regulatory guidance and standards related to ISO10993, the EU MDR, US FDA, and other global regulatory and standards organizations.  Furthermore, the sessions will explore solutions to the challenges associated with testing and manufacturing such as material availability, alternative materials, supplier diversification, manufacturing transfers, and more.

Read on marcusevans.com

For more than 20 years, every two years, the MDS International Meeting has been a milestone for those who are interested in myelodysplastic syndromes.

 During three days at MDS 2023, renowned international experts will present and discuss the recent advances in the field. The congress will cover basic and translational research, diagnosis, prognosis, new therapies and patient experiences. It will include several workshops and round tables in order to foster discussion. High-level research results, selected from the abstracts submitted by colleagues will also be presented.

Read on go.evvnt.com

The Translational Cell and Tissue Regenerative Medicine Summit is your premiere forum to network with 80+ industry experts for the first time. Gain an unrivalled overview of the translational and clinical development landscape, and explore novel approaches to regenerate tissue topography through cell and tissue transplant.

Developed in collaboration with key research and clinical development teams from Organmet Bio, AstraZeneca, Sana Bio, Nestle Research, GC Therapeutics, Boehringer Ingelheim and more. Leave this meeting with key lessons learned to design therapies with clinical utility, and optimize CMC and manufacturing for safe, efficacious tissue therapies.

Read on go.evvnt.com

This longtime event connects top-performing sales training professionals to exchange cutting-edge training curriculum inclusive of strategy, process and collateral. Close the gap between tenured and new sales personnel and identify cost effective opportunities for new technology to support training programs. Through interactive discussions and case study presentations you will be equipped with new perspectives and methodologies to implement in your own organization’s curriculum. Benchmark with fellow training professionals on strategy and implementation and navigate solutions to today’s challenges within training development. Networking features enable you to build new relationships with attendees and exchange ideas in a collaborative setting. Reference program materials on-demand to implement what you learn.

Read on q1productions.com

Join NAHAM May 2-5, 2023, to reconnect with your colleagues in sunny Orlando, Florida for the premiere event in Patient Access. Explore education tailored to the current state of the profession, earn NAHAM-approved contact hours toward maintaining your certification and get ready to imagine, impact and influence the future of the profession

What to Expect

• Up to 32 sessions to choose from focused on overcoming staffing challenges, ways to inspire and encourage team success, understanding and overcoming challenges associated with prior authorizations, leadership skills for managing a Patient Access department, and building a career as a Patient Access professional.
• Game-changing insights from our keynote speaker who will help you support your staff teams and understand key trends in healthcare and technology. 
• Opportunities to network with Patient Access managers and leaders from facilities across the country. Following NAHAM safety procedures, you will connect with managers and directors from departments ranging from 0-100 full-time employees and 500+ beds.

Read on naham.org

Excipient World is the ONLY U.S. event focused exclusively on excipients. Our mission is to present cutting-edge scientific developments, formulation and technology advancements, quality production and the safe use of excipients, as well as regulatory mandates to better address the ever-changing global marketplace. The event brings buyers and suppliers together to explore new product innovations and potential collaborations. Excipient World 2023 will focus on the role excipients play in the future of innovator and generic drugs, biologics, biosimilars, OTC, medical device / combination products, veterinary medicine, and consumer healthcare.

Read on s6.goeshow.com

BRCA 2023: Moving Into the Mainstream represents a unique opportunity to look at all aspects of breast and ovarian cancer, and in particular the susceptibility genes, BRCA1 and BRCA2, which are responsible for a considerable fraction of early-onset breast cancer.

Clinicians and researchers from over 30 countries will gather for the ninth edition of this event which has come to be recognized as THE major international conference in the world that covers specific targeted therapies for hereditary cancer.

Read on go.evvnt.com

Uniting leading CMC, Regulatory, QC, Analytical and Process Development experts, the 4th Annual Gene Analytical Development Europe Summit is the industry's definitive and only meeting focused on tackling the greatest analytical development challenges in the context of gene therapy drug development.

Hear from the likes of AstraZeneca, MHRA, Gyroscope, REGENXBIO, Biogen, Spark Therapeutics, and more across three days and two tracks of in-depth case studies, interactive panel discussions, dedicated Q and A time, and highly appraised networking opportunities to meet and learn from the leaders of this pioneering field.

Don't miss the opportunity to network with 80+ analytical experts to overcome your analytical challenges encountered in every stage of the gene therapy development life cycle.

Read on europe.com